EquityZen Growth Technology Fund LLC - Series 1177
Raised
$210K
Investors
8
Min Invest
$10,044
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1177 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on April 6, 2022, raising $210K from 8 investors under exemptions 506(b) and 3(c)(1). The fund requires a $10K minimum investment and is part of the EquityZen platform, which operates 1,889 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO pooled investment vehicle follows the typical EquityZen platform structure, utilizing 506(b) private placement and 3(c)(1) investment company exemptions with a $10K minimum investment threshold accessible to retail accredited investors. The raise size and investor count align with EquityZen's established single-company SPV model for facilitating secondary market liquidity in private growth-stage technology companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
